Literature DB >> 15526209

In vitro fermentation characteristics of a mixture of Raftilose and guar gum by human faecal bacteria.

Khalid M Khan1, Christine A Edwards.   

Abstract

BACKGROUND: The therapeutic effects of indigestible carbohydrates in the human colon are well known. Most fermentation studies have examined only single carbohydrates. Considering the idiosyncratic actions of individual carbohydrates and the dose required, it is unlikely that any one carbohydrate will provide ideal physiological actions without having some undesirable effects. Little is known of how mixing non-digestible carbohydrates affects their fermentation. This necessitates fermentation studies using different carbohydrates in mixtures. AIM OF THE STUDY: The aim of this study was to test the effect of mixing Raftilose (R) and guar gum (G) on short chain fatty acid (SCFA) production in in vitro cultures of human faecal bacteria.
METHOD: The fermentation of the individual carbohydrates (10 mg/ml) was compared with that of a 50:50 mixture in anaerobic in vitro cultures of human faeces.
RESULTS: Cultures of R/G mixtures produced significantly more n-butyrate than 100 mg G alone at 8 and 24 hours (p < 0.02). There was no significant difference in the production of n-butyrate between cultures of 100 mg R and the R/G mixture at 8 and 24 hours. R (100 mg) produced a propionic/butyric (p/b) acid ratio of 1.18 compared with 3.88 for 100 mg G, whereas R/G mixture produced a p/b ratio of 2.01.
CONCLUSION: The fermentation of R/G mixture was different compared with 100 mg of R or G alone. There was no loss of n-butyrate in the culture containing R/G (50 mg of each) mixture compared with the 100 mg R culture.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526209     DOI: 10.1007/s00394-004-0537-4

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  22 in total

1.  Propionate lowers blood glucose and alters lipid metabolism in healthy subjects.

Authors:  T Todesco; A V Rao; O Bosello; D J Jenkins
Journal:  Am J Clin Nutr       Date:  1991-11       Impact factor: 7.045

2.  Dietary fiber: in vitro methods that anticipate nutrition and metabolic activity in humans.

Authors:  J Adiotomre; M A Eastwood; C A Edwards; W G Brydon
Journal:  Am J Clin Nutr       Date:  1990-07       Impact factor: 7.045

3.  Moderation of lactulose-induced diarrhea by psyllium: effects on motility and fermentation.

Authors:  N Washington; M Harris; A Mussellwhite; R C Spiller
Journal:  Am J Clin Nutr       Date:  1998-02       Impact factor: 7.045

Review 4.  Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease.

Authors:  P B Mortensen; M R Clausen
Journal:  Scand J Gastroenterol Suppl       Date:  1996

Review 5.  The short-chain fatty acid butyrate induces apoptosis in colorectal tumour cell lines.

Authors:  A Hague; C Paraskeva
Journal:  Eur J Cancer Prev       Date:  1995-10       Impact factor: 2.497

6.  Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigs.

Authors:  M J Govers; N J Gannon; F R Dunshea; P R Gibson; J G Muir
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

7.  Wheat bread supplemented with depolymerized guar gum reduces the plasma cholesterol concentration in hypercholesterolemic human subjects.

Authors:  D E Blake; C J Hamblett; P G Frost; P A Judd; P R Ellis
Journal:  Am J Clin Nutr       Date:  1997-01       Impact factor: 7.045

8.  Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers.

Authors:  C S Venter; H H Vorster; J H Cummings
Journal:  Am J Gastroenterol       Date:  1990-05       Impact factor: 10.864

9.  Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines.

Authors:  B G Heerdt; M A Houston; L H Augenlicht
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

10.  Treatment of diabetes with guar gum. Reduction of urinary glucose loss in diabetics.

Authors:  D J Jenkins; T M Wolever; T D Hockaday; A R Leeds; R Howarth; S Bacon; E C Apling; J Dilawari
Journal:  Lancet       Date:  1977-10-15       Impact factor: 79.321

View more
  3 in total

1.  Dihydrodaidzein-producing Clostridium-like intestinal bacterium, strain TM-40, affects in vitro metabolism of daidzein by fecal microbiota of human male equol producer and non-producers.

Authors:  Motoi Tamura; Sachiko Hori; Hiroyuki Nakagawa
Journal:  Biosci Microflora       Date:  2011-08-15

2.  Analysis of the Anti-Cancer Effects of Cincau Extract (Premna oblongifolia Merr) and Other Types of Non-Digestible Fibre Using Faecal Fermentation Supernatants and Caco-2 Cells as a Model of the Human Colon.

Authors:  Samsu U Nurdin; Richard K Le Leu; Graeme P Young; James C R Stangoulis; Claus T Christophersen; Catherine A Abbott
Journal:  Nutrients       Date:  2017-04-03       Impact factor: 5.717

3.  Impact of Glycosidic Bond Configuration on Short Chain Fatty Acid Production from Model Fermentable Carbohydrates by the Human Gut Microbiota.

Authors:  Hannah C Harris; Christine A Edwards; Douglas J Morrison
Journal:  Nutrients       Date:  2017-01-01       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.